The Long Run with Luke Timmerman Ep176: David Roblin on Building a TechBio Company
Mar 31, 2025
David Roblin, CEO of Relation Therapeutics, delves into the revolutionary use of multi-omic tools and machine learning in drug discovery. He discusses the power of collaboration within London's biotech scene and shares insights from his journey from clinical medicine to the pharmaceutical industry. Roblin highlights the importance of teamwork, the impact of non-coding DNA on disease understanding, and how AI integration is transforming drug development. His fascinating perspective on interdisciplinary science and partnerships offers a glimpse into the future of biopharma innovation.
AI Snips
Chapters
Transcript
Episode notes
Welsh Roots
- David Roblin comes from a Welsh family with a background in teaching and music.
- His upbringing emphasized education, music, sport, and teamwork.
Teamwork and Mission
- Surround yourself with people who are better than you in their respective fields.
- Focus on the "what" and "why" of your organization's mission.
Path to Medicine
- David Roblin chose biochemistry and medicine because they were challenging fields.
- He pursued medicine after someone suggested he was smart enough for it.